CV Sciences (CVSI) Common Equity (2011 - 2026)

CV Sciences (CVSI) has 16 years of Common Equity data on file, last reported at $1.5 million in Q1 2026.

• For the quarter ending Q1 2026, Common Equity fell 20.82% year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2026 stood at $1.5 million (down 20.82% YoY), and the FY2025 full-year result was $1.5 million, down 18.22% from the prior year.
• Common Equity grew to $1.5 million in Q1 2026, from $1.5 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $5.0 million in Q1 2023 to a low of -$777000.0 in Q4 2022.
• A 5-year average of $2.3 million and a median of $1.9 million in 2025 frame the typical range for Common Equity.
• Across the five-year window, Common Equity sank 121.93% in 2022 and soared 473.62% in 2023, its largest moves.
• Tracing CVSI's Common Equity over 5 years: stood at -$777000.0 in 2022, then soared by 473.62% to $2.9 million in 2023, then plunged by 38.17% to $1.8 million in 2024, then retreated by 18.22% to $1.5 million in 2025, then climbed by 2.04% to $1.5 million in 2026.
• Business Quant data shows CVSI's Common Equity at $1.5 million in Q1 2026, $1.5 million in Q4 2025, and $1.5 million in Q3 2025.